Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04564703
Title Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors European Myeloma Network
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD | ITA | GRC | FRA

Facility Status City State Zip Country Details
CHU Hôtel-Dieu, 1, place Alexis Ricordeau, 44093 NANTES Cedex 1, FRANCE Nantes France Details
Alexandra General Hospital -Department of Clinical Therapeutics N.K. Univ. of Athens Athens Greece Details
Ospedale Generale Regionale-Divisione di Ematologia e Centro Trapianto Midollo Osseo Bolzano Italy Details
Vrije Universiteit Medical Center (VUMC) Amsterdam Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field